Avanos Medical, Inc. (AVNS)
$
12.52
+0.28 (2.24%)
Key metrics
Financial statements
Free cash flow per share
2.4729
Market cap
579 Million
Price to sales ratio
0.8401
Debt to equity
0.1679
Current ratio
2.5685
Income quality
-0.3520
Average inventory
138.4 Million
ROE
-0.3734
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Avanos Medical, Inc. is a prominent medical technology company specializing in medical device solutions across North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The financial data pertains to the fiscal year 2024 where the gross profit stands at $381,300,000.00 highlighting the company's profitability from core operations. The operating income ratio is -0.58 indicating the company's operational profitability margin. Furthermore, the net income ratio is -0.57 reflecting the company's profitability margin. Avanos boasts a portfolio of chronic care products, including digestive health solutions like Mic-Key enteral feeding tubes and Corpak patient feeding solutions, as well as respiratory health products such as closed airway suction systems under the Ballard brand. In addition, the company offers a range of non-opioid pain solutions, encompassing acute pain products like On-Q surgical pain pumps and interventional pain solutions with therapies such as Coolief pain relief. The diluted EPS is -$8.53 accounting for potential share dilution. The company, which was formerly known as Halyard Health, Inc. and rebranded to Avanos Medical, Inc. in June 2018, was incorporated in 2014 and is headquartered in Alpharetta, Georgia. In terms of market presence, the stock is affordable at $12.52 suitable for budget-conscious investors, and manifests a low average trading volume of 478,962.00 indicating lower market activity. With a market capitalization of $578,974,880.00 the company is classified as a small-cap player, reflecting its size and growth potential. Avanos Medical, Inc. is a key player in the Medical - Devices industry, contributing significantly to the overall market landscape. It operates within the Healthcare sector, driving innovation and growth while catering to the needs of hospitals, healthcare providers, and end-user customers through direct marketing and third-party distribution channels.
Is Avanos Medical, Inc. (AVNS) a good investment?
Investing in Avanos Medical, Inc. (AVNS) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bullish outlook. Always conduct your own research before investing.
What is Avanos Medical, Inc. (AVNS)'s stock forecast?
Analysts predict Avanos Medical, Inc. stock to fluctuate between $11.75 (low) and $25.36 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Avanos Medical, Inc.'s market capitalization?
As of 2025-07-01, Avanos Medical, Inc.'s market cap is $578,974,880, based on 46,244,000 outstanding shares.
How does Avanos Medical, Inc. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Avanos Medical, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Avanos Medical, Inc. (AVNS) stock?
To buy Avanos Medical, Inc. (AVNS) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AVNS. Place an order (Market, Limit, etc.).
What is the best time to invest in Avanos Medical, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did Avanos Medical, Inc. perform in the last earnings report?
Revenue: $687,800,000 | EPS: -$8.53 | Growth: 541.35%.
Where can I find Avanos Medical, Inc.'s investor relations reports?
Visit https://avanos.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Avanos Medical, Inc.?
You can explore historical data from here
What is the all-time high and low for Avanos Medical, Inc. stock?
All-time high: $53.61 (2021-02-18) | All-time low: $11.75 (2025-06-23).
What are the key trends affecting Avanos Medical, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
prnewswire.com
ALPHARETTA, Ga. , June 9, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) a leading medical technology company focused on delivered innovative healthcare solutions, today announced the appointment of Camille Chang Gilmore as senior vice president and chief human resources officer.
zacks.com
Strength in Avanos' SNS segment drives its first-quarter 2025 performance despite global macroeconomic challenges.
seekingalpha.com
Avanos Medical, Inc. (NYSE:AVNS ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy and Corporate Development Dave Pacitti - Chief Executive Officer Jason Pickett - Interim Chief Financial Officer and Treasurer Conference Call Participants Rick Wise - Stifel Daniel Stauder - Citizens JMP Operator Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos First Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Tuesday, May 6, 2025.
zacks.com
Avanos Medical (AVNS) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.22 per share a year ago.
prnewswire.com
ALPHARETTA, Ga. , April 28, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2025 on Tuesday, May 6 at 9 a.m.
zacks.com
Avanos takes direct control of MIC-KEY sales in the UK, enhancing market presence, customer engagement and service efficiency, starting July 2025.
zacks.com
AVNS, CARS and CABO have been added to the Zacks Rank #5 (Strong Sell) List on March 18, 2025.
prnewswire.com
ALPHARETTA, Ga. , March 17, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025.
zacks.com
AVNS, CSX and STZ have been added to the Zacks Rank #5 (Strong Sell) List on March 3, 2025.
zacks.com
Strength in Avanos' Digestive Health segment drives its fourth-quarter 2024 performance despite global macroeconomic challenges.
See all news
